HIGH CR RATES IN RELAPSED/REFRACTORY (R/R) AGGRESSIVE B‐NHL TREATED WITH THE CD19‐DIRECTED CAR T CELL PRODUCT JCAR017 (TRANSCEND NHL 001). (June 2017) - Abramson, J.; Palomba, M.L.; Gordon, L.; Lunning, M.; Arnason, J.; Wang, M.; Forero‐Torres, A.; Albertson, T.; Allen, T.; Sutherland, C.; Xie, B.; Garcia, J.; et al.